PRCT
$18.82+2.95%
PROCEPT BioRobotics CorporationStock · HealthcareRussell 2000 · 0.04% of IWMNasdaq Composite · 0.005% of ONEQUS Stock Market · 0.002% of VTIRussell 3000 · 0.002% of IWV
PRCT financial statements
The full income statement, balance sheet, and cash-flow statement for PROCEPT BioRobotics Corporation (PRCT), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
Shares outstanding (point-in-time)
2024-06 51.9M2024-09 52.2M2024-12 54.8M2025-03 55.3M2025-06 55.6M2025-09 55.9M2025-12 56.4M2026-03 56.9M2026-06 57.3M+10.3% over 8 periods
SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.
PeriodRangeOrderChangeFiguresAs-reported fiscal years.
| Line item | Trend | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Income Statement | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Revenue | 308M+37.2% | 224M+64.8% | 136M+81.6% | 75.0M+117.6% | 34.5M+346.7% | |
| 196M+43.1% | 137M+93.0% | 71.0M+91.6% | 37.1M+133.8% | 15.9M+1364.1% | ||
| Cost of revenue | 112M+28.0% | 87.4M+34.2% | 65.1M+71.7% | 37.9M+103.8% | 18.6M+107.4% | |
| 300M+28.4% | 234M+29.7% | 180M+53.0% | 118M+68.2% | 70.0M+50.4% | ||
| Research & development | 71.3M+14.4% | 62.3M+28.6% | 48.4M+67.2% | 29.0M+52.6% | 19.0M+16.7% | |
| Selling, general & administrative | 229M+33.5% | 171M+30.1% | 132M+48.3% | 88.8M+74.0% | 51.0M+68.6% | |
| Amortization of intangibles | 300K+0.0% | 300K+0.0% | 300K+0.0% | 300K+0.0% | 300K+0.0% | |
| Provision for credit losses | 219K-73.9% | 840K | 0.00 | 0.00 | — | |
| Operating income | -104M-7.5% | -96.6M+11.5% | -109M-35.2% | -80.7M-49.0% | -54.2M-13.3% | |
| Interest expense | 3.59M-14.3% | 4.18M+4.7% | 4.00M-22.9% | 5.18M-10.8% | 5.81M+10.4% | |
| Interest & investment income | 12.2M+12.2% | 10.9M+44.3% | 7.55M+202.4% | 2.50M+3185.5% | 76.0K-58.7% | |
| Other non-operating income | -156K+84.8% | -1.03M-970.8% | -96.0K+52.7% | -203K-31.8% | -154K-516.0% | |
| Pre-tax income | -95.4M-4.8% | -91.0M+14.0% | -106M | — | — | |
| Income tax | 190K-48.4% | 368K+360.0% | 80.0K | 0.00 | 0.00 | |
| Net income | -95.6M-4.5% | -91.4M+13.7% | -106M-21.5% | -87.2M-45.6% | -59.9M-12.9% | |
| -$1.72+1.7% | -$1.75+21.9% | -$2.24-14.3% | -$1.96+46.0% | -$3.63+74.9% | ||
| EPS (basic) | -$1.72+1.7% | -$1.75+21.9% | -$2.24-14.3% | -$1.96+46.0% | -$3.63+74.9% | |
| Weighted-avg shares (basic) | 55.5M+6.6% | 52.1M+10.3% | 47.3M+6.4% | 44.4M+169.4% | 16.5M+349.9% | |
| Weighted-avg shares (diluted) | 55.5M+6.6% | 52.1M+10.3% | 47.3M+6.4% | 44.4M+169.4% | 16.5M+349.9% | |
| Balance Sheet | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 450M-6.5% | 482M+37.4% | 351M+28.6% | 273M-16.4% | 326M+195.8% | ||
| Cash & equivalents | 287M-14.1% | 334M+29.7% | 257M+15.9% | 222M-27.1% | 304M+203.9% | |
| Accounts receivable | 83.5M+0.0% | 83.5M+72.6% | 48.4M+216.8% | 15.3M+242.1% | 4.46M+188.2% | |
| Inventory | 70.7M+25.9% | 56.2M+41.3% | 39.8M+39.3% | 28.5M+117.1% | 13.1M+89.9% | |
| Prepaid expenses | 9.65M+14.1% | 8.45M+62.2% | 5.21M-15.6% | 6.17M+45.6% | 4.24M+156.6% | |
| 508M-4.9% | 534M+31.9% | 405M+30.8% | 309M-8.2% | 337M+167.5% | ||
| Property, plant & equipment | 30.4M+13.8% | 26.7M-7.1% | 28.7M+232.1% | 8.66M+71.6% | 5.04M-39.0% | |
| Operating lease right-of-use | 17.5M-7.4% | 18.9M-6.4% | 20.2M-13.8% | 23.5M+616.1% | 3.28M-29.3% | |
| Other non-current assets | 6.02M+135.6% | 2.56M+178.0% | 919K+1702.0% | 51.0K | 0.00 | |
| 65.8M+23.8% | 53.1M+15.7% | 45.9M+30.1% | 35.3M+117.3% | 16.2M+11.8% | ||
| Accounts payable | 17.3M+72.3% | 10.0M-25.7% | 13.5M+43.7% | 9.39M+362.8% | 2.03M+63.6% | |
| Deferred revenue | 13.0M+36.4% | 9.56M+69.1% | 5.66M+98.1% | 2.85M+178.5% | 1.02M+339.9% | |
| Short-term & current debt | — | — | — | — | 0.00-100.0% | |
| Current lease liability | 2.21M+15.9% | 1.91M+13.5% | 1.68M-20.9% | 2.13M+1.1% | 2.10M+23.2% | |
| Other current liabilities | 10.1M+24.5% | 8.09M+28.0% | 6.32M-15.4% | 7.47M+62.1% | 4.61M+133.1% | |
| 142M+7.9% | 132M+6.3% | 124M+10.4% | 112M+60.5% | 69.9M+7.6% | ||
| Long-term debt | 51.6M+0.3% | 51.5M+0.3% | 51.3M+0.2% | 51.2M+2.4% | 50.0M+12.6% | |
| Deferred revenue (non-current) | — | — | — | 0.00 | — | |
| Non-current lease liability | 24.7M-8.2% | 26.9M+2.6% | 26.2M+9.2% | 24.0M+1104.2% | 1.99M-51.4% | |
| Operating lease liability (total) | 26.9M-6.6% | 28.8M+3.3% | 27.9M+6.7% | 26.1M+537.3% | 4.10M-29.4% | |
| Other non-current liabilities | 147K-54.6% | 324K-37.3% | 517K | 0.00-100.0% | 200K+0.0% | |
| 366M-9.0% | 402M+43.3% | 281M+42.5% | 197M-26.2% | 267M+246.0% | ||
| Preferred stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Additional paid-in capital | 1.01B+6.3% | 948M+28.9% | 735M+34.7% | 546M+3.2% | 529M+2713.8% | |
| Retained earnings | -642M-17.5% | -546M-20.1% | -455M-30.4% | -349M-33.3% | -262M-29.7% | |
| Accumulated other comprehensive income | 37.0K-67.5% | 114K+35.7% | 84.0K+1500.0% | -6.00K+88.9% | -54.0K-285.7% | |
| Total liabilities & equity | 508M-4.9% | 534M+31.9% | 405M+30.8% | 309M-8.2% | 337M+167.5% | |
| Common shares issued | 56.3M+2.9% | 54.7M+7.8% | 50.8M+13.3% | 44.8M+2.6% | 43.7M+826.7% | |
| Common shares outstanding | 56.3M+2.9% | 54.7M+7.8% | 50.8M+13.3% | 44.8M+2.6% | 43.7M+826.7% | |
| Shares outstanding (cover) | 56.4M+2.9% | 54.8M+7.6% | 51.0M+13.6% | 44.9M+2.0% | 44.0M | |
| Cash Flow | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| -49.0M+50.6% | -99.2M+8.1% | -108M-34.4% | -80.4M-40.2% | -57.3M-18.6% | ||
| Depreciation & amortization | 6.39M+22.1% | 5.23M+37.5% | 3.81M+34.0% | 2.84M-14.5% | 3.32M+16.2% | |
| Intangible amortization | 300K+0.0% | 300K+0.0% | 300K+0.0% | 300K+0.0% | 300K+0.0% | |
| Share-based compensation | 47.6M+49.5% | 31.8M+66.4% | 19.1M+85.1% | 10.3M+172.3% | 3.80M+74.7% | |
| Change in receivables | 898K-97.5% | 36.0M+8.6% | 33.1M+206.3% | 10.8M+270.9% | 2.91M+470.3% | |
| Change in inventory | 14.5M-15.9% | 17.2M+76.8% | 9.75M-36.1% | 15.3M+149.0% | 6.12M+97.2% | |
| Change in payables | 6.65M+408.9% | -2.15M-137.2% | 5.79M+46.2% | 3.96M+387.6% | 812K+496.1% | |
| -9.36M-112.2% | -4.41M+82.5% | -25.2M-850.1% | -2.65M-348.1% | -592K-154.1% | ||
| Capital expenditure | 9.36M+112.2% | 4.41M-82.5% | 25.2M+850.1% | 2.65M+348.1% | 592K+154.1% | |
| Free cash flow | -58.3M+43.7% | -104M+22.2% | -133M-60.4% | -83.0M-43.3% | -57.9M-19.2% | |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 11.2M-93.8% | 180M+7.3% | 168M+4545.5% | 3.61M-98.6% | 262M+145.5% | ||
| Long-term debt issued | 0.00 | 0.00 | 0.00-100.0% | 51.2M | 0.00-100.0% | |
| Long-term debt repaid | 0.00 | 0.00 | 0.00-100.0% | 50.0M | 0.00 | |
| Common stock issued | 0.00-100.0% | 165M+1.7% | 162M | 0.00 | 0.00 | |
| Common stock repurchased | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividends paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net change in cash | -47.2M-161.7% | 76.5M+121.2% | 34.6M+143.5% | -79.4M-138.9% | 204M+250.9% | |
| Interest paid | 3.46M-12.8% | 3.97M-2.1% | 4.06M-5.5% | 4.29M-9.7% | 4.75M+19.7% | |
| Income taxes paid | 118K+47.5% | 80.0K-11.1% | 90.0K | — | — | |
| Valuation Ratios | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Market cap | 1.77B-59.8% | 4.41B+108.6% | 2.12B+13.9% | 1.86B+68.9% | 1.10B | |
| P/S | 5.8×-70.7% | 19.7×+8.1% | 18.2×-39.9% | 30.3×-5.2% | 31.9× | |
| P/B | 4.8×-55.8% | 11.0×+55.2% | 7.1×-16.0% | 8.4×+104.3% | 4.1× | |
| Source filing | 10-K | 10-K | 10-K | 10-K | 10-K |
About this data
Source: PRCT’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all PRCT filings on SEC EDGAR → Not investment advice.